Tag Archives: Astellas Pharma Europe

News
The Pharma Letter – Setting up a successful corporate giving program

Astellas shares in The Pharma Letter the success of Action on Fistula, and the benefits of setting up an inspirational corporate giving program. Investing in a corporate giving program can be hugely beneficial, not just for the communities your organization supports, but also your business. As well as giving back to society and helping to…

News

Fistula Foundation was featured in a HiviSasa article about Action on Fistula treatment services becoming available at Kisumu District Hospital. Action on Fistula is a three year partnership between Fistula Foundation and Astellas Pharma Europe, Ltd. to transform the landscape of fistula treatment in Kenya. Kisumu Hospital Opens Fistula Theatre Kisumu District Hospital will soon…

Astellas - Action on Fistula

News
Action on Fistula: New partnership a ‘game changer’ for women in Kenya

On May 23, the United Nations’ International Day to End Obstetric Fistula, Astellas Pharma Europe, Ltd., the European headquarters of Tokyo-based Astellas Pharma Inc., announced that Fistula Foundation had been selected as the focus of the organization’s flagship corporate giving program, which aims to provide treatment to women who suffer from obstetric fistula in Kenya….

News
Extra funding to fight fistula in Kenya

This post appeared on the website of FIGO (International Federation of Gynecology and Obstetrics) on June 21, 2014. US-based charity The Fistula Foundation has received a $2 million grant to support its Action on Fistula scheme in Kenya. Voice of America reports that the grant represents the largest single chunk of funding ever received by the organisation,…

Voice of America

News
Funding Boosts Fistula Treatment Program in Kenya

An interview with Fistula Foundation CEO Kate Grant was featured on Voice of America’s website this week. The interview focuses on the physical and social consequences of obstetric fistula and how the new $2 million Action on Fistula program will help women suffering from this devastating condition in Kenya. The story was also picked up…

News
Fistula Foundation featured on VOA Swahili Service

In this four-part series from VOA Swahili Service, host Esther Githui Ewart leads a discussion on obstetric fistula, its causes and consequences, and what’s being done in East Africa to address it, including the recent launch of Action on Fistula, a joint effort between Astellas Pharma Europe Ltd. and Fistula Foundation. Included in the segment…

Voice of America

News
VOA Interview with CEO Kate Grant

Voice of America features a “Health News” segment every Tuesday and Thursday hosted by Linord Moudou that discusses the latest health topics in Africa. In this edition, Linord interviews Fistula Foundation CEO Kate Grant about the new Action on Fistula program launched by Astellas Pharma Europe Ltd. and Fistula Foundation and how this program will…

Voice of America

News
VOA Health Chat — Interview with Kate Grant & Dr. Hillary Mabeya

Voice of America’s ‘Health Chat’ is a live weekly call-in program that addresses health issues of interest to Africa. In this edition, host Linord Moudou interviews Kate Grant, CEO of Fistula Foundation, & Dr. Hillary Mabeya, founder of and lead surgeon at our partner site, Gynocare, about obstetric fistula and the new Action on Fistula…

News
Kenya gets “game changing” record donation for fistula treatment

 Published on the 2nd annual UN International Day to End Obstetric Fistula, this article features comments from Fistula Foundation CEO Kate Grant and Astellas Pharma Europe President & CEO Ken Jones on the new Action on Fistula program in Kenya. The story was also featured on Women’s News Network, The Guardian, and AllAfrica. By Katy…

News
Astellas Funds Fistula Project in Kenya

Fistula Foundation is mentioned in PharmaTimes, in an article about Astellas Pharma Europe’s generous donation via Action on Fistula.  By Kevin Grogan Astellas has unveiled a programme designed to transform the lives of more than 1,200 women in Kenya living with obstetric fistula. As part of a three-year initiative, the company is putting up 1.5…

News
Fistula Foundation, Astellas Announce Groundbreaking €1.5m ($2M) Program to Tackle Obstetric Fistula in Kenya

Funding will help treat 1,200 women with life-changing surgery and support major outreach project Astellas Pharma EMEA (APEL), the European Headquarters of Tokyo-based Astellas Pharma Inc., today announces a groundbreaking program, Action on Fistula, an initiative led by the charity Fistula Foundation, which is funded by APEL. This three-year initiative (between 2014-2017) will aim to transform…